Mr. Jim Hutchens reports

IMAGIN MEDICAL ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS

Imagin Medical Inc. has released the results of its annual general meeting of shareholders held on Dec. 17, 2018.

All of the matters put forward before the shareholders, as set out in the company's management information circular dated Nov. 15, 2018, were approved by the requisite majority of votes cast at the meeting. Specifically, De Visser Gray LLP was appointed as the company's auditor for the ensuing year, and Jim Hutchens, Dr. Robin Atlas, Kenneth Daignault, John Vacha and Chris Bleck were appointed as directors.

The biographies of all members of the board are available at the company's website.

About Imagin Medical Inc.

Imagin Medical is developing new imaging solutions for the detection and visualization of cancer. Imagin Medical believes its technology will radically improve cancer care during minimally invasive procedures, improving the surgeon's ability to visualize, identify and remove cancerous cells. Imagin Medical's initial target market is bladder cancer, the sixth most common cancer in the United States, and the costliest cancer to treat due to a greater than 50-per-cent recurrence rate.

We seek Safe Harbor.